Tumor-specific activity of precision medicines in the NCI-MATCH trial.

Published in: medRxiv : the preprint server for health sciences (2023)

These findings support the value of basket trials because even when precision medicines do not have tumor-agnostic activity, basket trials can identify tumor-specific activity for future study.

Keyphrases

clinical trial
study protocol
phase ii